Illness	Number of cases
Haemorrhage from respiratory passages - Epistaxis (R04.0)	192
Chronic diseases of tonsils and adenoids - Hypertrophy of adenoids (J35.2)	92
Dizziness and giddiness (R42)	85
Other hearing loss (H91.2)	82
Other disorders of nose and nasal sinuses - Deviated nasal septum (J34.2)	65
Chronic diseases of tonsils and adenoids - Hypertrophy of tonsils with hypertrophy of adenoids (J35.3)	39
Other malignant neoplasms of skin (C44.3)	37
Other disorders of ear not elsewhere classified (H93.1)	24
Chronic sinusitis - Chronic pansinusitis (J32.4)	23
Chronic diseases of tonsils and adenoids (J35.0)	22

Top 10 treatments

Treatment	Number
Measurement of hearing - audiometry (1-242)	778
Exchange or removal of the absorbent pack used to stop bleeding (tamponade) (8-506)	357
Treatment of a nose bleed by packing with absorbent material (tamponade) (8-500)	321
Surgical treatment of nosebleeds (5-210.1)	205
Computed tomography (CT) of the head without contrast medium (3-200)	181
Measurement of smell and taste (1-247)	158
Surgical removal of the (enlarged) adenoids (without removal of the tonsils) (5-285.0)	134
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.1)	124
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.8)	121
Other examination of the function of the nervous system (1-20a.30)	119

Further information about the department

Out-patient accident insurance doctor approval

Yes

In-patient Employers’ Liability Insurance Association approval

Yes

Department key

Department key: 2600

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
44	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
35	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
20	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility